Slingerlands, NY, United States of America

Bruce Francis Molino

This inventor holds 41 USPTO granted patents, plus 2 CIPO patents and 8 EPO patents, primarily in Bromodomain Inhibitors. Top assignees: Albany Molecular Research, Inc., Parion Sciences, Inc., Bristol-Myers Squibb Compnay. Active years: 2001-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce Francis Molino. Retrieved from https://idiyas.com/inventor/bruce-francis-molino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41

% Patents Active = 48.8

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 715(Granted Patents)

Company Filing History:

18 out of 97

Albany Molecular Research, Inc.

patents

11 out of 83

Parion Sciences, Inc.

patents

8 out of 3,742

Bristol-Myers Squibb Compnay

Zenith Epigenetics Corp.

patents

6. 1 out of 207

Aventis Pharmaceuticals Inc.

patents

7. 1 out of 23

Aventis Pharmaceuticals Products Inc.

patents

where one patent can have more than one assignee

Years Active: 2001-2020

Loading Chart...

Areas of Expertise:

Bromodomain Inhibitors

Cyclospirins

Sodium Channel Blockers

Heterocyclic Compounds

Tetrahydroisoquinolines

Aryl Substituents

Pharmaceutical Agents

Antithrombotic Peptides

Pyridinones

Alkyne Analogues

Dopamine Reuptake

Serotonin Reuptake

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10710992 - Substituted pyridinones as bromodomain inhibitors (2020-07-14),

2. 10179125 - Substituted pyridines as bromodomain inhibitors (2019-01-15),

3. 9861637 - Heterocyclic compounds as bromodomain inhibitors (2018-01-09),

4. 9604960 - Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof (2017-03-28),

5. 9598367 - Heterocyclic compounds as bromodomain inhibitors (2017-03-21),

6. 9499531 - Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2016-11-22),

7. 9403776 - Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2016-08-02),

8. 9271978 - Heterocyclic compounds as bromodomain inhibitors (2016-03-01),

9. 9096546 - Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2015-08-04),

10. 9085531 - Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2015-07-21),

11. 9045468 - 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2015-06-02),

12. 9034899 - Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof (2015-05-19),

13. 8987252 - Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2015-03-24),

14. 8802696 - 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof (2014-08-12),

15. 8791101 - Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2014-07-29),

Title: The Innovative Journey of Bruce Francis Molino

Introduction: Bruce Francis Molino, a talented inventor hailing from Slingerlands, NY (US), has made significant contributions to the field of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Bruce Francis Molino holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to complex challenges.

Career Highlights: Throughout his career, Bruce Francis Molino has demonstrated a keen ability to identify gaps in the market and develop groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of revolutionary products that have improved the lives of many.

Collaborations: Bruce Francis Molino has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work effectively in a team setting has allowed him to leverage the expertise of others and achieve remarkable results.

Conclusion: Bruce Francis Molino's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His impact on various industries is undeniable, and his legacy as an inventor will continue to inspire future generations.

Profile summary based on public USPTO records.